For instance, there is a subpopulation of tumor-associated neutrophils whose origin is from CD11b+CD15hiCD10−CD16low immature progenitors that can cross-present antigens, and trigger and augment anti-tumor T cell responses [198]. This evidence concerns the gene ITGAM and neoplasm.